HWP
AZN icon

Highline Wealth Partners’s AstraZeneca AZN Stock Holding History

Highline Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.4K Buy
+314
New +$59.1K 0.01% 209
2026
Q1 		– Sell
-274
Closed -$50.4K – 1302
2025
Q4 		$50.4K Buy
274
+8
+3% +$1.4K 0.01% 138
2025
Q3 		$40.8K Buy
266
+64
+32% +$9.69K 0.01% 170
2025
Q2 		$28.2K Sell
202
-6
-3% -$841 0.01% 179
2025
Q1 		$30.6K Buy
208
+170
+447% +$24.6K 0.01% 164
2024
Q4 		$4.98K Sell
38
-62
-62% -$8.68K ﹤0.01% 341
2024
Q3 		$15.5K Buy
100
+44
+79% +$7.1K 0.01% 210
2024
Q2 		$8.73K Buy
56
+46
+460% +$6.92K ﹤0.01% 239
2024
Q1 		$1.35K Hold
10
– – ﹤0.01% 351
2023
Q4 		$1.35K Hold
10
– – ﹤0.01% 324
2023
Q3 		$1.35K Buy
+10
New +$1.37K ﹤0.01% 294

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Highline Wealth Partners's AZN Position: Q2 2026 in Review

Highline Wealth Partners opened a new position in AstraZeneca (AZN) in Q2 2026: 314 shares worth $59.4K. The stake represents 0.01% of the portfolio and ranks #209 among its holdings. This is a return to the name: Highline Wealth Partners previously reported a position in AZN as recently as Q4 2025.

Highline Wealth Partners first reported a position in AZN in Q3 2023 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Highline Wealth Partners held 314 shares of AstraZeneca worth $59.4K as of Q2 2026.
  • AstraZeneca was a new Highline Wealth Partners position in Q2 2026.
  • AstraZeneca made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #209 holding.
  • Highline Wealth Partners first reported a position in AstraZeneca in Q3 2023 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.